Immunis
Irvine
About Immunis
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2024)
- Website: immunisbiomedical.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immunis-54159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.